.
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A106856430
Toru Sugiyama (Iwate Medical University School of Medicine) ; Satoshi Takeuchi (Iwate Medical University School of Medicine) ; Hiroaki Itamochi (Iwate Medical University School of Medicine)
2017
English
KCI등재,SCIE,SCOPUS
학술저널
1-3(3쪽)
0
0
상세조회0
다운로드참고문헌 (Reference)
1 Nguyen JM, "Uterine clear cell carcinoma: does adjuvant chemotherapy improve outcomes?" 27 : 69-76, 2017
2 Malcolm D. Mattes, MD, "The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry" 대한부인종양학회 26 (26): 19-24, 2015
3 Thomas M, "Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review" 108 : 293-297, 2008
4 Marino BD, "Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread" 56 : 34-38, 1995
5 Velker V, "Role of adjuvant therapy for stage IA serous and clear cell uterine cancer: is observation a valid strategy?" 26 : 491-496, 2016
6 Mustafa Erkan Sarı, "Prognostic factors and treatment outcomes in surgicallystaged noninvasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study" 대한부인종양학회 28 (28): 1-13, 2017
7 Saygili U, "Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma" 11 : 471-474, 2001
8 National Comprehensive Cancer Network (US), "NCCN Clinical Practice Guidelines in Oncology. Uterine neoplasms, version 2. 2017" National Comprehensive Cancer Network 2017
9 Olawaiye AB, "Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review" 113 : 277-283, 2009
10 Ebina Y, "Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms" 21 : 419-434, 2016
1 Nguyen JM, "Uterine clear cell carcinoma: does adjuvant chemotherapy improve outcomes?" 27 : 69-76, 2017
2 Malcolm D. Mattes, MD, "The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry" 대한부인종양학회 26 (26): 19-24, 2015
3 Thomas M, "Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review" 108 : 293-297, 2008
4 Marino BD, "Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread" 56 : 34-38, 1995
5 Velker V, "Role of adjuvant therapy for stage IA serous and clear cell uterine cancer: is observation a valid strategy?" 26 : 491-496, 2016
6 Mustafa Erkan Sarı, "Prognostic factors and treatment outcomes in surgicallystaged noninvasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study" 대한부인종양학회 28 (28): 1-13, 2017
7 Saygili U, "Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma" 11 : 471-474, 2001
8 National Comprehensive Cancer Network (US), "NCCN Clinical Practice Guidelines in Oncology. Uterine neoplasms, version 2. 2017" National Comprehensive Cancer Network 2017
9 Olawaiye AB, "Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review" 113 : 277-283, 2009
10 Ebina Y, "Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms" 21 : 419-434, 2016
11 Kim A, "Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma" 81 : e639-644, 2011
12 Colombo N, "ESMO-ESGOESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up" 27 : 16-41, 2016
13 Kurman RJ, "Clear cell carcinoma of the endometrium: an analysis of 21 cases" 37 : 872-882, 1976
14 Creasman WT, "Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer" 95 (95): S105-143, 2006
Genotypespecific methylation of HPV in cervical intraepithelial neoplasia
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | |
2012-07-13 | 학회명변경 | 한글명 : 대한부인종양콜포스코피학회 -> 대한부인종양학회영문명 : Korean Society of Gynecologic Oncology and Colposcopy -> Korean Society of Gynecologic Oncology | |
2012-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2011-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2010-01-01 | 평가 | 등재후보학술지 유지 (등재후보2차) | |
2009-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2008-06-26 | 학술지명변경 | 한글명 : 부인종양 -> Journal of Gynecologic Oncology외국어명 : Korean Journal of Gynecologic Oncology -> Journal of Gynecologic Oncology | |
2008-01-01 | 평가 | 등재후보 1차 FAIL (등재후보1차) | |
2007-01-01 | 평가 | 등재후보학술지 유지 (등재후보1차) | |
2006-09-13 | 학술지명변경 | 한글명 : 대한부인종양.콜포스코피학회지 -> 부인종양외국어명 : 미등록 -> Korean Journal of Gynecologic Oncology | |
2005-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 2.18 | 0.12 | 1.48 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
1.13 | 0.9 | 0.732 | 0 |